This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Innovations by Eun-Young Kwon
Introduction
Eun-Young Kwon is a notable inventor based in Goyang, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the areas of obesity and sarcopenia treatment. With a total of 2 patents, his work is recognized for its innovative approaches to health-related issues.
Latest Patents
Eun-Young Kwon's latest patents include a composition for preventing, alleviating, or treating sarcopenia, which contains D-ribo-2-hexulose as an active ingredient. Additionally, he has developed a pharmaceutical composition comprising an extract of Platycodon grandiflorum, along with a method for preventing or treating obesity using this extract. This composition is designed to prevent, improve, or treat obesity by inhibiting increases in body weight and fat mass caused by a high-fat diet. The extract demonstrates a superior effect compared to those prepared by conventional methods, making it a promising solution for obesity-related complications.
Career Highlights
Eun-Young Kwon is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work has garnered attention for its potential impact on public health, particularly in combating obesity and its associated health risks.
Collaborations
Eun-Young Kwon collaborates with notable colleagues, including Myung-Sook Choi and Ye Jin Kim. Their combined expertise contributes to the advancement of research in their respective fields.
Conclusion
Eun-Young Kwon's innovative contributions to pharmaceutical compositions highlight his commitment to addressing significant health challenges. His patents reflect a dedication to improving treatment options for conditions like obesity and sarcopenia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile